State officials said Thursday that an adult daycare worker in Illinois has tested positive for monkeypox.
All children and adults at the center are being screened, and no new cases have been found so far. The governor of Illinois has been in contact with the White House.
State officials said that the Jynneos vaccine was approved by the FDA for children under the age of 18.
The adult, who works for a home health care agency, is being monitored and is doing well.
In an interview with Fortune on Friday, Dr. Lindsey Baden said he wasn't surprised by the news.
He said it was a transmissible disease. It is not like a respiratory virus that can spread quickly. We need to get control of this now by giving vaccines to people who need them and make sure it doesn't spread.
An "overreaction" that could give the virus a lot more power over us than it deserves is what the senior scholar at the center for health security is worried about.
The public is now very aware of infectious disease risk and the incident would probably receive less attention had it happened before.
He said thatMonkeypox isn't a virus that can spread very quickly. Countermeasures can be used to counteract it. We have to not think about it in the same way.
State health officials said that monkeypox is not a sexually transmitted disease. Close physical contact is one of the ways it can be transmitted. Most of the identified cases have been in men who have sex with men.
It can be transmitted through direct contact with bodily fluids of people who have been bitten or scratched by an animal.
Julie Pryde is the administrator of the Champaign-Urbana Public Health District in Illinois.
According to data from the U.S. Centers for Disease Control and Prevention, 7,510 cases have been identified in the U.S. Every state except for Wyoming and Montana has had at least one case.
Almost all of the cases reported since January were in countries where monkeypox is not considered endemic. The US leads the world in identified cases, followed by Spain, Germany, the UK, France, and Brazil. In African countries where the virus is endemic, only 345 cases have been seen since the beginning of the year. The World Health Organization said that 81 children had been exposed to the disease.
People in rural African areas have close contact with rats and Squirrels, which can carry the monkeypox. In countries where the virus has not been seen before, recent cases have occurred, and in individuals without a travel history, indicating that it has been circulating undetected for some time.
The population has a low level of immunity against poxviruses as a result of the eradication of smallpox and the vaccine for it. It means that could happen.
According to the CDC, the symptoms are not as bad as those of smallpox. Initial symptoms include fatigue, headaches, and achy muscles. A rash can start on the face and spread to other parts of the body within a few days. Lesions progress through different stages before they stab someone. Two to four weeks is how long the illness lasts. The typical period is 7 to 14 days, but can range from 5 to 21 days.
Health officials have said that symptoms in new cases seem to differ from those of classic cases with recent reports of lesions more subtle than usual.
The Secretary of the U.S. Department of Health and Human Services declared a public health emergency on Thursday after federal health officials said they were considering breaking single doses of vaccine into multiple smaller doses.
We are prepared to take our response to the next level in addressing the virus. We want every American to help us fight this disease.
More than 1.1 million doses of the Jynneos vaccine have been made available so far by the federal government. Almost 7 million doses have been secured by the U.S.
The vaccine was opened up by the federal health officials on Friday and they were able to start filling orders this week. They plan to open up another round of ordering on August 15th, though they will be able to place an order sooner if more of their supply is used.
There isn't enough supply. A process called "dose sparing" is being considered by the FDA to expand its supply. Health care providers would be able to split a single dose of Jynneos into five different amounts. Instead of being injected under the skin, the vaccine would be administered between layers of skin.
Califf said that the approach provides improved immune response to the vaccine.
Health officials said Thursday that they would likely make a decision on dose sparing within the next few days and that it was looking good.
The secretary of the HHS can allow the FDA to authorize unauthorized uses of approved medical products in emergency situations if there is no adequate, approved, and available alternatives.
According to the agency, there are emergency use authorizations for COVID vaccines and treatments, as well as products for H7N9 flu, Middle East Respiratory Syndrome coronaviruses, nerve agent, and the like.
The demand for the vaccine was higher than the supply. According to the New York Times, the vaccine shortage is due to the HHS failing to ask the manufacturer of bulk vaccine early enough to convert it into a form that's less toxic.
Most of the requests are for the vaccine. The ACAM2000 vaccine is housed in the National Strategic Stockpile. It can have serious side effects, including stillbirth and life threatening infections. Women who are pregnant or breastfeeding, people with weakened immune systems, and people with heart disease are considered unsafe.
If you sign up for the email list, you will be kept up to date with our biggest features, exclusive interviews, and investigations.
All Rights Reserved © 2024
